We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+5.27%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$805M
AUM Growth
+$13.4M
Cap. Flow
-$23.9M
Cap. Flow %
-2.97%
Top 10 Hldgs %
44.94%
Holding
152
New
20
Increased
16
Reduced
39
Closed
7

Top Sells

Rank Stock Value
1
KEY icon
KeyCorp
KEY
+$3.18M
2
AAPL icon
Apple
AAPL
+$2.22M
3
CMCSA icon
Comcast
CMCSA
+$2.06M
4
TMO icon
Thermo Fisher Scientific
TMO
+$1.94M
5
AIG icon
American International
AIG
+$1.67M

Sector Composition

Rank Sector Weight
1 Financials 25.5%
2 Healthcare 18.94%
3 Technology 16.09%
4 Industrials 13.05%
5 Consumer Discretionary 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
26
Fortive
FTV
$18.9B
$9.91M 1.23%
248,172
-246
-0.1% -$9.68K
JNJ icon
27
Johnson & Johnson
JNJ
$633B
$6.8M 0.85%
51,399
+405
+0.8% +$51.7K
AXS icon
28
AXIS Capital
AXS
$8.59B
$4.75M 0.59%
73,523
UNH icon
29
UnitedHealth
UNH
$381B
$4.22M 0.52%
22,763
-863
-4% -$151K
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$3.51M 0.44%
14,526
+150
+1% +$35.9K
UNB icon
31
Union Bankshares
UNB
$115M
$2.82M 0.35%
59,357
-1,675
-3% -$71.8K
XOM icon
32
ExxonMobil
XOM
$650B
$2.76M 0.34%
34,134
-2,271
-6% -$186K
AON icon
33
Aon
AON
$76.9B
$2.66M 0.33%
20,041
+1,500
+8% +$190K
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.39M 0.3%
14,124
+1,200
+9% +$200K
BIIB icon
35
Biogen
BIIB
$29.9B
$1.93M 0.24%
7,115
TRMB icon
36
Trimble
TRMB
$12.2B
$1.85M 0.23%
52,000
WFC icon
37
Wells Fargo
WFC
$262B
$1.81M 0.22%
32,635
-30
-0.1% -$1.61K
PG icon
38
Procter & Gamble
PG
$344B
$1.76M 0.22%
20,248
VBR icon
39
Vanguard Small-Cap Value ETF
VBR
$37.2B
$1.7M 0.21%
+13,820
New +$1.69M
MRK icon
40
Merck
MRK
$324B
$1.67M 0.21%
27,338
ADNT icon
41
Adient
ADNT
$1.61B
$1.66M 0.21%
25,311
-2,302
-8% -$157K
KMI icon
42
Kinder Morgan
KMI
$72.9B
$1.65M 0.2%
85,932
IBB icon
43
iShares Biotechnology ETF
IBB
$9.38B
$1.57M 0.19%
15,174
SBUX icon
44
Starbucks
SBUX
$119B
$1.29M 0.16%
22,049
BRK.A icon
45
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.27M 0.16%
5
IWF icon
46
iShares Russell 1000 Growth ETF
IWF
$123B
$1.27M 0.16%
42,560
MMM icon
47
3M
MMM
$89.1B
$1.21M 0.15%
6,966
-144
-2% -$24.1K
CCI icon
48
Crown Castle
CCI
$33.2B
$1.18M 0.15%
11,725
ARMK icon
49
Aramark
ARMK
$15.2B
$1.14M 0.14%
38,586
VEA icon
50
Vanguard FTSE Developed Markets ETF
VEA
$227B
$1.13M 0.14%
27,405
-7,185
-21% -$293K

Similar funds

Cannell & Spears's Q2 2017 Portfolio in Review

As of Q2 2017, Cannell & Spears held 152 positions worth $805M, up 1.7% from $791M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cannell & Spears's Q2 2017 filing shows 20 new, 16 increased, 39 reduced and 7 closed positions. Its largest new stake was Vanguard Small-Cap Value ETF: 13,820 shares worth $1.7M. The largest sale was KeyCorp, an estimated $3.18M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

  • Cannell & Spears's largest Q2 2017 buy was Vanguard Small-Cap Value ETF: 13,820 shares worth $1.7M.
  • Cannell & Spears added most to GE Aerospace in Q2 2017, an estimated $684K increase.
  • Cannell & Spears's biggest Q2 2017 reduction was Apple, cutting an estimated $2.22M.
  • Cannell & Spears fully exited KeyCorp in Q2 2017, selling an estimated $3.18M.
  • Cannell & Spears's ten largest holdings make up 45% of its $805M portfolio in Q2 2017.
  • Cannell & Spears opened 20 new positions and closed 7 in Q2 2017.
  • Cannell & Spears's portfolio value rose 1.7% quarter-over-quarter to $805M.

Based on Cannell & Spears's 13F filing for Q2 2017, filed 11 Aug 2017.